3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
3
Sarcoma
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Osteosarcoma
1
Mouth Neoplasms
1
Interventions
pembrolizumab
11
Nivolumab
4
Erlotinib Hydrochloride
3
Docetaxel
3
Cetuximab
3
Capecitabine
3
tislelizumab
2
spartalizumab
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Gemcitabine
2
Filgrastim
2
Cyclophosphamide
2
tremelimumab
1
sargramostim
1
ribociclib
1
poly ICLC
1
pexidartinib
1
mirabegron
1
futibatinib
1
etoposide phosphate
1
entinostat
1
durvalumab
1
ciforadenant
1
cemiplimab
1
capivasertib
1
bempegaldesleukin
1
avelumab
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Positron Emission Tomography Computed Tomography
×
Sarcoma
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled